Case_id: case_1236
Case_description: 
A 45-year-old woman presents to the physician with a history of headache, palpitations, and episodic diaphoresis. She was diagnosed with hypertension in the past and is now regularly taking antihypertensive medication (amlodipine 10 mg once daily). She has had a diffuse thyroid swelling for the past 4 months. She complains of pain in the long bones of her arms and legs for the past 3 months. She is slightly built, appears thin, and is anxious and apprehensive. Her skin is moist and warm. Her weight is 45 kg (99.2 lb) and height is 146 cm (4 ft 7 in); BMI is 21.12 kg/m2. Her pulse is 116/min, the blood pressure is 196/102 mm Hg, the respiratory rate is 29/min, and the temperature is 37.2°C (99.0°F). Diffuse and firm thyromegaly is present. Her upper extremities exhibit fine tremors during an anxiety attack. The laboratory test results reveal elevated 24-hour urinary VMA and metanephrines. Serum epinephrine, calcitonin, and parathormone levels are also elevated. Hypercalcemia and hyperglycemia are also noted. Which of the following is the most likely diagnosis?
Options: 
1. Von Hippel-Lindau syndrome
2. Multiple endocrine neoplasia (MEN) 1
3. Multiple endocrine neoplasia (MEN) 2A
4. Multiple endocrine neoplasia (MEN) 2B
5. Neurofibromatosis
Correct Answer: Multiple endocrine neoplasia (MEN) 2A

================================================================================
Launch the MCC process
================================================================================
GPT is reasoning the answer...

GPT's diagnostic conclusion:
Choice: Option 3 (Multiple endocrine neoplasia (MEN) 2A)

GPT's full response:
================================================================================
**1. Case Summary and Key Symptoms**

- **Patient Information:** 45-year-old woman with a history of hypertension managed with amlodipine.
- **Chief Complaints:** Headache, palpitations, episodic diaphoresis.
- **Key Clinical Manifestations:**
  - Diffuse and firm thyromegaly present for 4 months.
  - Pain in the long bones of arms and legs for 3 months.
  - Physical signs of hyperthyroidism: thin build, moist and warm skin, fine tremors, anxiety, tachycardia (pulse 116/min), hypertension (BP 196/102 mm Hg), and increased respiratory rate (29/min).
- **Laboratory Findings:**
  - Elevated 24-hour urinary VMA and metanephrines.
  - Elevated serum epinephrine, calcitonin, and parathormone.
  - Hypercalcemia and hyperglycemia.

**2. Analysis of Clinical Features**

- **Catecholamine Excess Indicators:** Elevated urinary VMA and metanephrines, along with elevated serum epinephrine, suggest pheochromocytoma.
- **Thyroid Involvement:** Diffuse and firm thyromegaly combined with elevated calcitonin levels point towards medullary thyroid carcinoma.
- **Parathyroid Function:** Elevated parathormone and hypercalcemia indicate primary hyperparathyroidism.
- **Additional Features:** Bone pain in long bones may be related to hyperparathyroidism-induced osteoporosis or other metabolic bone disease.
- **Exclusion of Hyperthyroidism:** Although some features (e.g., weight loss, tachycardia) align with hyperthyroidism, the combination with calcitonin and parathormone elevations suggests a different underlying endocrine disorder.

**3. Differential Diagnosis Analysis**

1. **Von Hippel-Lindau Syndrome:**
   - **Features:** Pheochromocytoma, hemangioblastomas, renal cell carcinoma.
   - **Assessment:** Does not typically include medullary thyroid carcinoma or primary hyperparathyroidism. Less aligned with the current presentation.

2. **Multiple Endocrine Neoplasia (MEN) 1:**
   - **Features:** Parathyroid tumors, pancreatic endocrine tumors, pituitary adenomas.
   - **Assessment:** Absence of pancreatic or pituitary manifestations and presence of medullary thyroid carcinoma and pheochromocytoma make this less likely.

3. **Multiple Endocrine Neoplasia (MEN) 2A:**
   - **Features:** Medullary thyroid carcinoma, pheochromocytoma, primary hyperparathyroidism.
   - **Assessment:** Aligns perfectly with the patient's elevated calcitonin, catecholamine levels, and parathyroid hormone levels, along with clinical symptoms.

4. **Multiple Endocrine Neoplasia (MEN) 2B:**
   - **Features:** Medullary thyroid carcinoma, pheochromocytoma, mucosal neuromas, marfanoid habitus.
   - **Assessment:** The patient does not exhibit mucosal neuromas or marfanoid features, making MEN 2B less likely.

5. **Neurofibromatosis:**
   - **Features:** Neurofibromas, café-au-lait spots, pheochromocytoma (in NF1).
   - **Assessment:** Lack of neurofibromas or café-au-lait spots makes this an unlikely match.

**4. Final Selection**

**My final selection is: Option 3 (Multiple endocrine neoplasia (MEN) 2A) 多发性内分泌腺瘤综合征2A型**
================================================================================
Qwen is reasoning the answer...

Qwen's diagnostic conclusion:
Choice: Option 3 (Multiple endocrine neoplasia (MEN) 2A)

Qwen's full response:
================================================================================
**1. Case Summary and Key Symptoms**  
- A 45-year-old woman with hypertension, diffuse thyroid swelling, bone pain, anxiety, tremors, and elevated catecholamines (VMA, metanephrines, epinephrine).  
- Key features: **diffuse thyromegaly**, **elevated calcitonin** (indicative of medullary thyroid carcinoma), **elevated metanephrines and VMA** (pheochromocytoma), **hypercalcemia with elevated PTH** (primary hyperparathyroidism), and **uncontrolled hypertension**.  

**2. Analysis of Clinical Features**  
- **Hypertension**: Despite amlodipine use, BP is severely elevated (196/102 mm Hg), suggesting a catecholamine-secreting tumor (pheochromocytoma).  
- **Thyroid swelling**: Diffuse and firm thyromegaly may indicate **medullary thyroid carcinoma** (MTC), a hallmark of MEN 2 subtypes. Elevated calcitonin confirms MTC.  
- **Bone pain**: Likely due to **hypercalcemia** from coexisting primary hyperparathyroidism (elevated PTH).  
- **Sympathetic overactivity**: Tremors, diaphoresis, tachycardia, and anxiety align with pheochromocytoma.  
- **Hyperglycemia**: Could result from catecholamine excess or concurrent hyperparathyroidism.  

**3. Differential Diagnosis Analysis**  
- **Option 1 (Von Hippel-Lindau syndrome)**: Excluded due to lack of retinal angiomas, hemangioblastomas, or renal cell carcinoma.  
- **Option 2 (MEN 1)**: Involves parathyroid adenomas, pituitary tumors, and pancreatic neuroendocrine tumors. MTC and pheochromocytoma are absent in MEN 1.  
- **Option 3 (MEN 2A)**: **Fits perfectly**. Classic triad: **MTC**, **pheochromocytoma**, and **primary hyperparathyroidism**. All three features are present (elevated calcitonin, metanephrines, and PTH).  
- **Option 4 (MEN 2B)**: Includes MTC and pheochromocytoma but adds **marfanoid habitus**, **mucosal neuromas**, and **gastrointestinal ganglioneuromatosis**. The patient lacks these features.  
- **Option 5 (Neurofibromatosis)**: Characterized by café-au-lait spots and neurofibromas, which are absent here.  

**4. Final Selection**  
**My final selection is: Option 3 (Multiple endocrine neoplasia (MEN) 2A) (多发性内分泌腺瘤病2A型)**  

**Key Evidence**:  
- **Medullary thyroid carcinoma** (elevated calcitonin and thyromegaly).  
- **Pheochromocytoma** (elevated urinary VMA/metanephrines and hypertension symptoms).  
- **Primary hyperparathyroidism** (elevated PTH and hypercalcemia).  
These three components form the classic triad of MEN 2A. The absence of MEN 2B-specific features (e.g., neuromas, marfanoid build) excludes Option 4.
================================================================================
DeepSeek is reasoning the answer...

DeepSeek's diagnostic conclusion:
Choice: Option 3 (Multiple endocrine neoplasia (MEN) 2A)

DeepSeek's full response:
================================================================================
**1. Case Summary and Key Symptoms**  
- **Basic Information**: 45-year-old woman with hypertension (on amlodipine), diffuse thyroid swelling, bone pain, anxiety, and autonomic symptoms (palpitations, diaphoresis).  
- **Key Symptoms/Signs**:  
  - **Hypertensive crisis**: BP 196/102 mmHg, tachycardia (116/min), headaches.  
  - **Thyroid pathology**: Firm, diffuse thyromegaly.  
  - **Metabolic disturbances**: Hypercalcemia, hyperglycemia.  
  - **Neuroendocrine markers**: Elevated urinary VMA/metanephrines (pheochromocytoma), elevated calcitonin (medullary thyroid carcinoma, MTC), elevated parathormone (hyperparathyroidism).  
  - **Bone pain**: Likely due to hypercalcemia-induced bone resorption.  

**2. Analysis of Clinical Features**  
- **Timeline & Interrelationships**:  
  - Chronic thyroid swelling (4 months) + bone pain (3 months) + acute autonomic symptoms (palpitations, diaphoresis) align with progressive endocrine neoplasia.  
  - **Hypercalcemia + elevated PTH**: Primary hyperparathyroidism.  
  - **Elevated calcitonin**: Pathognomonic for MTC.  
  - **Elevated VMA/metanephrines + hypertension**: Pheochromocytoma.  
- **Critical Features Supporting MEN Syndromes**:  
  - **Triad of MTC, pheochromocytoma, hyperparathyroidism** is diagnostic for **MEN 2A**.  
  - **Opposing other options**:  
    - MEN 1: No pancreatic/pituitary tumors.  
    - MEN 2B: Absent mucosal neuromas/marfanoid habitus.  
    - Von Hippel-Lindau/Neurofibromatosis: Lack of renal/CNS tumors or neurocutaneous stigmata.  

**3. Differential Diagnosis Analysis**  
1. **Von Hippel-Lindau**: Pheochromocytoma is common, but lacks MTC/hyperparathyroidism. Excluded.  
2. **MEN 1**: Hyperparathyroidism is typical, but paired with pituitary/pancreatic tumors (absent here). Excluded.  
3. **MEN 2A**: Fits all features: MTC (elevated calcitonin + thyromegaly), pheochromocytoma (elevated catecholamines + hypertension), hyperparathyroidism (elevated PTH + hypercalcemia). Strongly supported.  
4. **MEN 2B**: Requires mucosal neuromas and marfanoid features (absent). Excluded.  
5. **Neurofibromatosis**: No neurofibromas/café-au-lait spots. Excluded.  

**4. Final Selection**  
**My final selection is: Option 3 (Multiple endocrine neoplasia (MEN) 2A)(多发性内分泌腺瘤病2A型)**  
- **Key Evidence**:  
  - **Triad of MEN 2A**: Elevated calcitonin (MTC), elevated VMA/metanephrines (pheochromocytoma), elevated PTH/hypercalcemia (hyperparathyroidism).  
  - Absence of MEN 2B or MEN 1 features.  
  - Clinical guidelines (e.g., NIH Consensus Criteria) confirm this triad as diagnostic for MEN 2A.
================================================================================

The three models have reached an initial consensus!
Correct Answer: Option 3 (Multiple endocrine neoplasia (MEN) 2A)

GPT's initial diagnosis is correct
Qwen's initial diagnosis is correct
DeepSeek's initial diagnosis is correct

The three models have reached an initial consensus!All models selected Option3

========= Final Debate Result =========
GPT, Qwen, and DeepSeek-R1 have reached a consensus!
Final diagnosis: Option3 - Multiple endocrine neoplasia (MEN) 2A
Correct Answer: - Multiple endocrine neoplasia (MEN) 2A

Is the final diagnosis correct? ✓ Correct

